Interferon alfa

This page covers all Interferon alfa drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Interferon-alpha receptor (IFNAR).

Targets

Interferon-alpha receptor (IFNAR)

Marketed (2)

• PEG-interferon alfa-2b · Barbara Ann Karmanos Cancer Institute · Oncology, Immunology, Virology
  PEG-interferon alfa-2b is a pegylated form of interferon alfa-2b that enhances and prolongs immune activation by binding to interferon-alpha receptors on immune cells.
• Peginterferon alfa-2b Injection · Nanfang Hospital, Southern Medical University · Immunology, Virology, Oncology
  Peginterferon alfa-2b is a pegylated form of interferon alfa-2b that binds to interferon-alpha receptors on immune cells to enhance antiviral and anti-tumor immune responses.

Phase 3 pipeline (1)

• placebo + PEGinterferon alfa-2a · SciClone Pharmaceuticals · Immunology
  PEGinterferon alfa-2a is an immunomodulatory agent that enhances antiviral and anti-tumor immune responses by activating interferon signaling pathways.